Search Results - "Er-Rajy, Mohammed"

Organic–inorganic hybrid phosphites (C2H10N2)[M(H2PO3)2Cl2] (M = Ni, Mn) for corrosion protection: Experimental and computational approaches.

Authors: Zerrouk, Mohammed Er-Rajy, Mohammed Ech-Chihbi, Elhachmia et al.

Source: Bulletin of Materials Science. Sep2026, Vol. 49 Issue 3, p1-13. 13p.

Computational modeling for rational design of novel phenoxy tacrine derivatives targeting Alzheimer's disease.

Authors: El Fadili, Mohamed Er-rajy, Mohammed Mujwar, Somdutt et al.

Source: PLoS ONE. 3/5/2026, Vol. 21 Issue 3, p1-22. 22p.

Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study.

Authors: Er-rajy, Mohammed El fadili, Mohamed Zarougui, Sara et al.

Source: Frontiers in Chemistry. 2025, p1-20. 20p.

Regioselective synthesis of novel spiro-isoxazolines congeners as antimicrobial agents: in vitro and in-silico assessments.

Authors: Bouzammit, Rachid Ait Assou, Soumia Er-Rajy, Mohammed et al.

Source: Frontiers in Chemistry. 2026, p1-18. 18p.

Computational Analysis of Triazolone-Based Dyes in DSSCs: Exploring Acceptor Terminal for Enhanced Photovoltaic Performance.

Authors: Etabti, Hanane Er-rajy, Mohammed Fitri, Asmae et al.

Source: Journal of Fluorescence. Oct2025, Vol. 35 Issue 10, p9333-9357. 25p.

Natural Solutions to Environmental Degradation: Antioxidant and Anticorrosive Activities of Mentha pulegium L. Essential Oil.

Authors: Rached, Sara Mzioud, Khaoula Rehioui, Malak et al.

Source: Chemistry (2624-8549). Apr2026, Vol. 8 Issue 4, p53. 23p.

3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer.

Authors: Er-rajy, Mohammed El fadili, Mohamed Imtara, Hamada et al.

Source: Life (2075-1729). Jan2023, Vol. 13 Issue 1, p127. 15p.

3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line.

Authors: Zarougui, Sara Er-Rajy, Mohammed Faris, Abdelmoujoud et al.

Source: Frontiers in Chemistry. 2024, p01-18. 18p.

In silico design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells.

Authors: Aloui, Mourad El fadili, Mohamed Er-rajy, Mohammed et al.

Source: Frontiers in Chemistry. 2025, p1-21. 21p.

QSAR, molecular docking, and molecular dynamics simulation–based design of novel anti-cancer drugs targeting thioredoxin reductase enzyme.

Authors: Er-rajy, Mohammed Fadili, Mohamed El Mujwar, Somdutt et al.

Source: Structural Chemistry. Aug2023, Vol. 34 Issue 4, p1527-1543. 17p.

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia.

Authors: El fadili, Mohamed Er-Rajy, Mohammed Kara, Mohammed et al.

Source: Pharmaceuticals (14248247). Jun2022, Vol. 15 Issue 6, p670-N.PAG. 22p.

2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives.

Authors: Er-rajy, Mohammed El Fadili, Mohamed Hadni, Hanine et al.

Source: Structural Chemistry. Jun2022, Vol. 33 Issue 3, p973-986. 14p.

In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer's disease.

Authors: Aloui, Mourad El fadili, Mohamed Mujwar, Somdutt et al.

Source: Scientific Reports. 5/7/2025, Vol. 15 Issue 1, p1-27. 27p.